Challenging tumor resistance with less toxic, more effective drug combinations: an example from neuroblastoma
نویسندگان
چکیده
منابع مشابه
Less Is More, More the Merrier, or More From Less?
P hysicians deal with uncertainty all the time and chest pain in the emergency department (ED) is a typical example. Traditionally, coronary artery disease (CAD), pulmonary embolism (PE), and aortic dissection can present as chest pain, and the consequences of a missed diagnosis can be devastating, with the potential for rapid deterioration, and serious risk of morbidity and mortality. Moreover...
متن کاملControl over Power Conversion Efficiency of BHJ Solar Cells: Learn more from Less, with Artificial Intelligence
Harvesting the energy from the sun through the bulk heterojunction (BHJ) solar cells need materials with specific electronic characteristics. However, any promising material if cast improperly in cells will end into low or even null power conversion efficiency (PCE). Cell casting optimization is a time/material consumable step in any photovoltaic manufacturing practice. In this study, we sh...
متن کاملLeishmania donovani Develops Resistance to Drug Combinations
Drug combinations for the treatment of leishmaniasis represent a promising and challenging chemotherapeutic strategy that has recently been implemented in different endemic areas. However, the vast majority of studies undertaken to date have ignored the potential risk that Leishmania parasites could develop resistance to the different drugs used in such combinations. As a result, this study was...
متن کاملNon-toxic antimicrobials that evade drug resistance
Drugs that act more promiscuously provide fewer routes for the emergence of resistant mutants. This benefit, however, often comes at the cost of serious off-target and dose-limiting toxicities. The classic example is the antifungal amphotericin B (AmB), which has evaded resistance for more than half a century. We report markedly less toxic amphotericins that nevertheless evade resistance. They ...
متن کاملMore with less Xist.
S ince the birth of Dolly, the first mammal produced from somatic cell nuclear transfer (SCNT), little progress has been made in the efficiency of cloning. Overall, about 0.5–2% of the embryos reconstructed by SCNT develop to term after transfer of reconstructed embryos to recipient females. In PNAS, Matoba et al. (1) report significant improvement in cloning efficiency by manipulation of the l...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cell Death & Disease
سال: 2018
ISSN: 2041-4889
DOI: 10.1038/s41419-018-0728-1